| Mrs Stacy Lee Rooney, MOTR/L | |
|
55 Tunxis Ave, Bloomfield, CT 06002-2005 | |
| (860) 242-0703 | |
| (860) 242-4086 |
| Full Name | Mrs Stacy Lee Rooney |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 55 Tunxis Ave, Bloomfield, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275873663 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 002877 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Stacy Lee Rooney, MOTR/L 55 Tunxis Ave, Bloomfield, CT 06002-2005 Ph: (860) 242-0703 | Mrs Stacy Lee Rooney, MOTR/L 55 Tunxis Ave, Bloomfield, CT 06002-2005 Ph: (860) 242-0703 |
News Archive
A research team at Massachusetts Eye and Ear has shown that microglia, the primary immune cells of the brain and retina, play a protective role in response to retinal detachment.
MedAssist has entered into a partnership with CarePayment to make affordable and flexible patient financing programs available as a complement to its eligibility, enrollment and revenue recovery services for hospitals and health systems nationwide. MedAssist's healthcare clients will be able to choose from a variety of CarePayment financing programs that feature credit lines with terms of up to 72 months at 0.00% APR, with no application or credit check.
A common drug that is used to treat high blood pressure in the general population has been found to significantly reduce a dangerous and frequently fatal cardiac problem in patients with Marfan syndrome.
Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Despite evidence and guidelines supporting the value of screening for this disease, rates of screening for colorectal cancer are consistently lower than those for other types of cancer, particularly breast and cervical.
Intra-Cellular Therapies, Inc. today announced the results from a Phase Ib/II clinical trial in patients with schizophrenia with ITI-007, the Company's unique, investigational new drug for the treatment of schizophrenia. The trial met its primary endpoint demonstrating that ITI-007 was safe and well-tolerated in patients with stabilized schizophrenia.
› Verified 5 days ago
Kaitlin Hill, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Seabury Dr, Bloomfield, CT 06002 Phone: 860-286-0243 | |
Mrs. Bethany Pisati, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Seabury Dr, Bloomfield, CT 06002 Phone: 186-028-6024 | |
Deborah Sutliff, COTA Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10 Loeffler Rd, Bloomfield, CT 06002 Phone: 860-726-2413 | |
Laura M Carlson, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 355 Park Ave, Bloomfield, CT 06002 Phone: 860-242-8595 | |
Katherine Genevieve Sendra, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 200 Seabury Dr, Bloomfield, CT 06002 Phone: 860-286-0243 | |
Karen Ann Logan, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 35 Jolley Dr, Suite 101, Bloomfield, CT 06002 Phone: 860-243-3434 Fax: 860-243-0208 |